Ignite Creation Date:
2025-12-26 @ 3:59 PM
Ignite Modification Date:
2025-12-29 @ 6:39 AM
Study NCT ID:
NCT01101906
Status:
TERMINATED
Last Update Posted:
2024-11-20
First Post:
2010-04-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC
Sponsor:
Astellas Pharma Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01-10
Start Date Type:
ACTUAL
Primary Completion Date:
2011-11-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-12-28
Completion Date Type:
ACTUAL
First Submit Date:
2010-04-08
First Submit QC Date:
None
Study First Post Date:
2010-04-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-12-12
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2024-11-18
Last Update Post Date:
2024-11-20
Last Update Post Date Type:
ACTUAL